WUXI BIOLOGICS (CAYMAN) INC earnings per share and revenue

2269 earnings per share for the last semiannual are 0.24 HKD whereas the estimation was 0.47 HKD which accounts for -48.86% surprise. Company revenue for the same period amounts to 10.75 B HKD despite the estimated figure of 10.29 B HKD. Estimated earnings per share for the next semiannual are 0.48 HKD, and revenue is expected to reach 10.42 B HKD. Also watch annual changes over time to get a bigger picture of 2269 earnings per share and revenue dynamics.